tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ritu Baral, 100 are a BUY (90.91%), 9 are a HOLD (8.18%), 1 are a SELL (0.91%).
Analyst Ritu Baral works at TD COWEN with a stock forecast success ratio of 56.41% fulfilled within 456.11 days on average.
Ritu Baral’s has documented 230 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SAGE, Sage Therapeutic at 17-Apr-2024.
Analyst best performing recommendations are on SRPT (SAREPTA THERAPEUTICS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 1/10/2023. The price target of $125 was fulfilled within 3 days with a profit of $5.87 (4.93%) receiving and performance score of 16.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$8.29 (49.61%)
29
1 months 6 days ago
5/8 (62.5%)
$7.16 (40.13%)
26
Buy
30
$13.29 (79.53%)
40
1 months 18 days ago
16/19 (84.21%)
$10.44 (53.37%)
184
Buy
39
$22.29 (133.39%)
40
2 months 3 days ago
6/10 (60%)
$15.25 (64.21%)
94
Buy
33
$16.29 (97.49%)
33
2 months 3 days ago
8/19 (42.11%)
$9.25 (38.95%)
119
Buy
36
$19.29 (115.44%)
2 months 3 days ago
0/1 (0%)
$12.25 (51.58%)
Which stock is Ritu Baral is most bullish on?
Which stock is Ritu Baral is most reserved on?
What Year was the first public recommendation made by Ritu Baral?
